Pharmacologic treatment of the adult hospitalized asthma patient

Clinical Reviews in Allergy and Immunology

Volumn 20, Issue 3, 2001, Pages 357-383

  Kreutzer, M L ^a   Louie, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; HELIOX; LEVALBUTEROL; LIDOCAINE; MAGNESIUM SULFATE; METOPROLOL; NITRIC OXIDE; OXYGEN; SALBUTAMOL; TERBUTALINE;

ASTHMA; BRONCHOSPASM; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPOKALEMIA; PATHOPHYSIOLOGY; REVIEW; TACHYCARDIA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; ASTHMA; CHILD; CHILD, PRESCHOOL; EMERGENCY MEDICAL SERVICES; HOSPITALIZATION; HUMANS; UNITED STATES;

EID: 0035019961     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1385/CRIAI:20:3:357     Document Type: Review

References (121)

1. Medical progress: Asthma
2. Causes of death and pathologic findings in 304 cases of bronchial asthma
3. The practical management of severe status asthmaticus
4. Exacerbations of asthma. A descriptive study of 425 severe exacerbations
5. Future directions in asthma therapy. Is a cure possible?
6. Status asthmaticus. A nine year experience
7. Preventing deaths from asthma
8. Medical progress: Asthma
9. Asthma mortality and hospitalization among children and adults. United States 1980-1993
10. Inhaled glucocorticoids and acute asthma. Therapeutic break-through or nonspecific effect?
11. Arterial-blood gas tension in asthma
12. Ventilation perfusion mismatching in acute severe asthma: Effects of salbutamol and 100% oxygen
13. The assessment and management of adults with status asthmaticus
14. Beta-adrenergic agonist therapy
15. Human pharmacologic and clinical studies on salbutamol: A specific beta-adrenergic bronchodilator
16. Selectivity of bronchodilator action of salbutamol in asthmatic patients
17. Improved bronchodilation with levalbuterol compared with racemic albuerol in patients with asthma
18. The fast onset and long duration of action of formoterol powder is maintained over time in asthma patients
19. New β2-agonist aerosols
20. The role of ipatropium bromide in the emergency treatment of acute asthma exacerbations: A Meta-analysis of randomized trials
21. Effect of nebulized ipatropium bromide on hospitalization rates of children with asthma
22. The role of ipatropium bromide in the emergency management of acute asthma exacerbation: A meta-analysis of randomized clinical trials
23. Effect of outpatient treatment of asthma on the response to sympathomimetics in the emergency room
24. Tolerance to bea-agonists during acute bronchoconstriction
25. Tolerance to beta-2 adrenoceptor agonists: Time for reappraisal
26. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma
27. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol
28. Long-acting beta-agonists, tachyphylaxis and corticosteroids
29. Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients
30. Tolerance to the non-bronchodilator effects of inhaled beta2-agonists in asthma
31. Emergency department treatment of severe asthma: Metered dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer
32. Cost benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients
33. Emergency department management of life-threatening asthma: Are nebulizers obsolete
34. Equivalence of continuous flow nebulizer and metered dose inhaler with reservoir bag for the treatment of acute airflow obstruction
35. Treatment of acute severe asthma with inhaled albuterol delivered via jetnebulizer, metered dose inhaler with spacer or dry powder
36. The use of beta-agonists and the risk of death and near death from asthma
37. Bronchodilators and acute cardiac death
38. Cardiovascular safety of high doses of inhaled formoterol and albuterol in acute severe asthma
39. Respiratory arrest in near fatal asthma
40. Paradoxical bronchospasm after use of inhalation aerosols: A review of the literature
41. Paradoxical bronchoconstriction with nebulized albuterol but not with terbutaline
42. Laryngospasm and paradoxical bronchoconstriction after repeated doses of beta-agonist containing edetate disodium
43. Molecular mechanism of beta-adrenergic relaxation of airway smooth muscle
44. Contrasting properties of albuterol stereoisomers
45. On the medical history of xanthines and other remedies for asthma
46. Fatal reactions to intravenous administration of aminophylline
47. Theophylline in asthma
48. Immunomodulation by theophylline in asthma: Demonstration by withdrawal of therapy
49. Theophylline in asthma
50. Aminophylline treatment in severe, acute asthma
51. Does aminophylline benefit adults admitted to the hospital for an acute exacerbation of asthma?
52. Aminophylline in the treatment of acute asthma when beta-2 adrenergics and steroids are provided
53. Inhaled albuterol and oral prednisone therapy in hospitalized adult asthmatics. Does aminophylline add any benefit?
54. A comparison of ipatropium and albuterol vs albuterol alone in the treatment of acute asthma
55. The effect of adding ipatropium bromide to salbutamol in the treatment of acute asthma
56. Efficacy and safety of inhaled corticosteroids in asthma
57. Efficacy and safety of inhaled corticosteroids, New developments
58. Current therapies in asthma. Promise and limitatins
59. A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor downregulation after regular inhaled formoterol
60. Early administration of corticosteroids in the emergency room treatment of acute asthma
61. Fatal asthma
62. Fluticasone propionate aerosole for the treatment of adults with mild to moderate asthma
63. The acute effects of corticosteroids in bronchial asthma
64. Effectiveness of steroid therapy in acute exacerbations of asthma: A meta-analysis
65. Effects of corticosteroids on airway hyper-responsiveness
66. Systemic adverse effects of inhaled corticosteroid therapy. A systematic review and meta-analysis
67. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma
68. Issues in the use of inhaled glucocorticoids
69. Aerosol glucocorticoid treatment of asthma
70. Inhaled flunisolide for acute severe asthma
71. Steroid- resistant asthma
72. Steroid resistant asthma
73. Glucocorticoid resistance in asthma
74. Leukotriene receptor antagonists: Useful in acute asthma?
75. Comparison of the effects of intravenous and oral montelukast on airway function: A double blind placebo controlled three period crossover study in asthmatic patients
76. Leukotriene modifiers and the Churg-Strauss syndrome
77. Seven cases of complete and incomplete forms of Churg-Strauss syndrome not related to leukotriene receptor antagonists
78. Immunomodulation as asthma therapy: Where do we stand
79. Intracellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma
80. Treatment of allergic asthma with monoclonal anti-IgE antibody
81. Blood serum magnesium in bronchial asthma and its treatment by the administration of magnesium sulfate
82. Magnesium, the mimic/antagonist of calcium
83. The nature of the neuromscular block produced by magnesium
84. The relation between magnesium, blood histamine level and eosinophilia in the acute stage of allergic reactions in humans
85. Evidence that prostacyclin mediates the vascular action of magnesium in humans
86. Effect of magnesium chloride on rabbit bronchial smooth muscle
87. Magnesium metabolism
88. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department
89. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma
90. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus
91. Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations
92. Intravenous magnesium for acute asthma: Failure to decrease emergency treatment duration or need for hospitalization
93. A trial of nebulized magnesium sulfate to reverse bronchospasm in asthmatic patients
94. Extreme hypermagnesemia as a cause of refractory hypotension
95. Intravenous lidocaine and mexiletine block reflex bronchoconstriction in asthmatic subjects
96. The response to lidocaine in bronchial asthma
97. Both intravenous and inhaled lidocaine attenuate reflex bronchoconstriction but at different plasma concentrations
98. Endogenous nitrogen oxides and bronchodilator S-notrosothiols in human airways
99. Bronchodilator action of inhaled nitric oxide in guinea pigs
100. Inhalation of nitric oxide modulates adult human bronchial tone
101. Nitric oxide and airway disease
102. Nitric oxide and lung disease
103. Inhaled bronchodilator therapy in mechanically ventilated patients
104. Aerosol delivery during mechanical ventilation: A predictive in vitro lung model
105. Nebulizer function during mechanical ventilation
106. Albuterol delivery in a model of mechanical ventilation: Comparison of metered dose inhaler and nebulizer efficiency
107. Deposition of aerosol from metered dose inhaler during mechanical ventilation: An in vitro model
108. Bronchodilator delivery by metered dose inhaler in mechanically ventilated COPD patients: Influence of end-inspiratory pause
109. Aerosol delivery in intubated mechanically ventilated patients
110. Metered dose inhaled vs nebulized albuterol in mechanical ventilated patients
111. A comparison of bronchodilator therapy delivered by nebulization and metered dose inhaler in mechanically ventilated patients
112. Can metered dose inhaler be used effectively by extubated ICU patients?
113. Pregnancy and asthma
114. The course of asthma during pregnancy, post-partum, and with successive pregnancies: A prospective analysis
115. Asthma in pregnancy
116. Management of asthma during pregnancy
117. Infant and maternal outcomes in the pregnancies of asthmatic women
118. Antibiotics in chronic pulmonary disease exacerbations. A meta-analysis
119. Community-acquired pneumonia in adults: Guidelines for management. Guidelines from the Infectious Disease Society of America
120. Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease